Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Cognis, Lonza Invest In Nutrition Ingredients

Specialty chemical makers buy businesses that make extracts from fish, trees

by Michael McCoy and Patricia L. Short
May 18, 2006

Chemical makers Cognis and Lonza are buying businesses that extract nutritional ingredients from natural sources.

Cognis is acquiring Napro Pharma AS, a Norwegian manufacturer of omega-3 fish oils for the nutrition industry. Napro produces fish oil concentrates in ethyl ester and triglyceride forms. According to Cognis, the company expanded its facilities earlier this year with a new distillation unit and other equipment.

Market forecasts indicate the market for omega-3 fish oils is growing at about 12% annually, with concentrates leading the category, Cognis says.

Lonza, meanwhile, has acquired Larex' business in larch arabinogalactan (LAG), a soluble fiber extracted from larch trees. The purchase includes intellectual property, processing technology, and a facility in Cohasset, Minn.

According to Lonza, LAG is a bioactive compound used in human and animal nutrition, personal care, and industrial applications. The company says the purchase expands its portfolio of nutrition businesses. Late last year, Lonza acquired Celanese's business in docosahexaenoic acid, considered an important omega-3 fatty acid.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.